# Sinotau: Pharmaceuticals, China

> Sinotau: Sinotau, officially known as Beijing Sinotau International Pharmaceutical Technology Co., Ltd., is an innovative pharmaceutical company based in...

Source: https://millionrounds.com/startup/sinotau (Millionrounds; every figure on the page links to its filing or article)

China · [Pharmaceuticals startup](https://millionrounds.com/companies)

# Sinotau

Sinotau, officially known as Beijing Sinotau International Pharmaceutical Technology Co., Ltd., is an innovative pharmaceutical company based in Beijing, China.

Funding reported Last round: Series E

Pharmaceuticals China

Follow Sinotau and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fsinotau)

Company summary

- **Founded:** 2005 21 years old
- **Team:** 12 11 to 50 people
- **Funding reported:** 2B as listed, currency not stated
- **Last round:** Series E Jul 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Sinotau has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Sinotau

Sinotau, officially known as Beijing Sinotau International Pharmaceutical Technology Co., Ltd., is an innovative pharmaceutical company based in Beijing, China.

Founded in 2005, Sinotau specializes in the research, development, manufacturing, and marketing of next-generation radiopharmaceuticals. The company focuses on targeted radionuclide theranostics, which integrate diagnostic imaging and targeted radiotherapy to enhance precision medicine. Sinotau offers a comprehensive range of services across the radiopharmaceutical value chain, including early-stage discovery, clinical development, regulatory support, and commercialization. Its product portfolio features targeted radiopharmaceuticals aimed at oncology, neurodegenerative diseases, and cardiovascular disorders. Notable developments include agents for prostate cancer diagnosis and Alzheimer’s disease, with several products at various stages of clinical development. Sinotau has established modern production facilities in multiple regions of China and has secured significant financing to support its innovative initiatives. The company aims to expand its market reach both domestically and internationally through collaborations with global partners.

## What company datasets say Sinotau raised

Funding, as reported

Reported in all **2B** in the source's currency

Rounds **5**

Last round **Series E**

Last round size **151.3M**

Last round date **Jul 2023**

Investors listed **29**

## On a portfolio page

Investors who name them

- [Qiming Venture Partners](https://millionrounds.com/fund/qiming-venture-partners)

Each firm lists Sinotau on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care medical innovation pharmaceutical innovation phase iii clinical trials radioconjugate development marketing manufacturing oncology imaging neurodegenerative diseases medical research cardiology innovative radioconjugates hospital & health care diagnostic imaging theranostic agents medical

Built with from their website

WordPress.org HREF Lang WOW Viewport Meta MySQL PrimeNG Mobile Friendly Multilingual jQuery RSS

+8 more

Swiper Amap ICP Lightbox WPML Alibaba Cloud Mail Wordpress jQuery Migrate

- **Sector:** Pharmaceuticals
- **Industry code:** NAICS 325412, SIC 2834
- **Region:** Bei Jing Shi
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/sinotau)

## Pharmaceuticals in China

Startups like it

- [**InventisBio** Shanghai · founded 2013 *Raised*](https://millionrounds.com/company/inventisbio)
- [**Alpha Biopharma** Shanghai · founded 2017 *Raised*](https://millionrounds.com/company/alpha-biopharma)
- [**IMPACT Therapeutics** founded 2009 *Raised*](https://millionrounds.com/company/impact-therapeutics)
- [**Laviana** Taizhou · founded 2003 *Raised*](https://millionrounds.com/company/laviana)
- [**Naxions** Beijing · founded 2015 *Raised*](https://millionrounds.com/company/naxions)
- [**Shanghai Cell Therapy Group** founded 2013](https://millionrounds.com/startup/shanghai-cell-therapy-group)
- [**Huisheng Biopharmaceutical Co., Ltd** founded 2014](https://millionrounds.com/startup/huisheng-biopharmaceutical-co-ltd)
- [**HealSun Biopharm** Hangzhou · founded 2015](https://millionrounds.com/startup/healsun-biopharm)

## Is this your company?

Add your raise, your deck and your story, and put Sinotau in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)